Dec 5, 2024, 18:25
Vadim Koshkin: Our recent editorial on the critical role of FGFR inhibitors in Bladder Cancer
Vadim Koshkin, Associate Professor of Clinical Medicine UC San Francisco, shared a post on X, about a recent paper by him and Guru Sonpavde, Oncology and Phase I Clinical Trials Director at AdventHealth Central Florida, published in European Urology.
“Our recent European Urology editorial with Guru Sonpavde, on the critical role of FGFR inhibitors in Bladder Cancer commenting on Roger Li paper.”
“Expanding the Reach of FGFR Inhibitors to Advance Precision Medicine in Urothelial Carcinoma”
Authors: Vadim Koshkin and Guru Sonpavde.
More posts featuring Vadim Koshkin.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 5, 2024, 17:49
Dec 5, 2024, 17:33
Dec 5, 2024, 17:18